Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,699 | -20,538 | -14,542 | -7,499 | -21,622 |
| Depreciation Amortization | 1,879 | 1,383 | 896 | 425 | 1,538 |
| Accounts receivable | 1,996 | -531 | 56 | 1,089 | -4,028 |
| Other Working Capital | -877 | -2,859 | -1,444 | -488 | -5,833 |
| Other Operating Activity | 5,341 | 5,238 | 2,746 | 202 | 9,371 |
| Operating Cash Flow | $-22,360 | $-17,307 | $-12,288 | $-6,271 | $-20,574 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -32 | -32 | -32 | N/A |
| Purchase Sale Intangibles | -561 | -434 | -313 | -149 | -350 |
| Other Investing Activity | -561 | -434 | -313 | -149 | -350 |
| Investing Cash Flow | $-593 | $-466 | $-345 | $-181 | $-350 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -9,317 |
| Common Stock Issued | 6,433 | 6,421 | 1,853 | 1,405 | 103,680 |
| Other Financing Activity | -485 | -385 | -296 | -204 | -6,930 |
| Financing Cash Flow | $5,948 | $6,036 | $1,557 | $1,201 | $87,433 |
| Exchange Rate Effect | 244 | 42 | 934 | -149 | 2,604 |
| Beginning Cash Position | 83,913 | 83,913 | 83,913 | 83,913 | 14,800 |
| End Cash Position | 67,152 | 72,218 | 73,771 | 78,513 | 83,913 |
| Net Cash Flow | $-16,761 | $-11,695 | $-10,142 | $-5,400 | $69,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,360 | -17,307 | -12,288 | -6,271 | -20,574 |
| Capital Expenditure | -32 | -32 | -32 | -32 | N/A |
| Free Cash Flow | -22,392 | -17,339 | -12,320 | -6,303 | -20,574 |